CorFlow has conducted an extensive market research study which included an in-depth survey of 207 interventional cardiologists across Europe (54) and the US (153). The study documents an overwhelming support for CorFlow’s technology to meet an unmet need, including the following findings:
The CoFI-System is not approved in the United States of America. It is an investigational device limited by federal law to investigational use and is not available for commercial distribution.
VAT:CHE 320.873.257 MWST
© 2023 Corflow. All Rights Reserved.